Clinical activity and safety of anti-PD1 (BMS-936558, MDX-1106) in patients with advanced non-small-cell lung cancer (NSCLC).
暂无分享,去创建一个
L. Sequist | S. Gettinger | J. Wigginton | A. Gupta | L. Gandhi | D. Spigel | G. Kollia | S. Antonia | J. Brahmer | L. Horn | D. McDonald